FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erfan Mansouri

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Phenomena

Safety

Co-author Network

Publications

TOP 3
Wolfram G Metzger; Erfan Mansouri; M Kronawitter; Susanne Diescher; M Soerensen; Robert Hurwitz; Dirk Bumann; Toni Aebischer; Bernd Ulrich von Specht; Thomas F Meyer
Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Ulrich Baumann; Erfan Mansouri; Bernd Ulrich von Specht
Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
Erfan Mansouri; Sigrid Blome-Eberwein; Josef Gabelsberger; Günter Germann; Bernd Ulrich von Specht
Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erfan Mansouri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Wolfram G Metzger; Erfan Mansouri; M Kronawitter; Susanne Diescher; M Soerensen; Robert Hurwitz; Dirk Bumann; Toni Aebischer; Bernd Ulrich von Specht; Thomas F Meyer
Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Vaccine 2004;22(17-18):2273-7.
2004: Ulrich Baumann; Erfan Mansouri; Bernd Ulrich von Specht
Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
Vaccine 2004;22(7):840-7.
2003: Erfan Mansouri; Sigrid Blome-Eberwein; Josef Gabelsberger; Günter Germann; Bernd Ulrich von Specht
Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
FEMS immunology and medical microbiology 2003;37(2-3):161-6.
2002: Helen Melzer; Paola Fortugno; Erfan Mansouri; Franco Felici; Alexandra Marinets; Gerhard Wiedermann; Herwig Kollaritsch; Bernd Ulrich von Specht; Michael Duchêne
Antigenicity and immunogenicity of phage library-selected peptide mimics of the major surface proteophosphoglycan antigens of Entamoeba histolytica.
Parasite immunology 2002;24(6):321-8.
2001: Dirk Bumann; Wolfram G Metzger; Erfan Mansouri; O Palme; Meike Wendland; Robert Hurwitz; Gaby Haas; Toni Aebischer; Bernd Ulrich von Specht; Thomas F Meyer
Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.
Vaccine 2001;20(5-6):845-52.
2001: M Larbig; Erfan Mansouri; Joachim Freihorst; B Tümmler; G Köhler; Horst Domdey; Bettina Knapp; Klaus D Hungerer; Erika Hundt; Josef Gabelsberger; Bernd Ulrich von Specht
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
Vaccine 2001;19(17-19):2291-7.
2000: Helen Melzer; Franco Felici; Erfan Mansouri; Paola Fortugno; Alexandra Marinets; Gerhard Wiedermann; Herwig Kollaritsch; Bernd Ulrich von Specht; Michael Duchêne
Isolation of phage mimotopes mimicking a protective epitope of GPI-linked proteophosphoglycan antigens of Entamoeba histolytica.
Archives of medical research 2000;31(4 Suppl):S309-10.
1999: Bettina Knapp; Erika Hundt; U Lenz; Klaus D Hungerer; Josef Gabelsberger; Horst Domdey; Erfan Mansouri; Y Li; Bernd Ulrich von Specht
A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa.
Vaccine 1999;17(13-14):1663-6.
1999: Erfan Mansouri; Josef Gabelsberger; Bettina Knapp; Erika Hundt; U Lenz; Klaus D Hungerer; Harry E Gilleland; John Staczek; Horst Domdey; Bernd Ulrich von Specht
Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
Infection and immunity 1999;67(3):1461-70.